Basics Tempest Therapeutics, Inc. IPO Date: December 7, 2012 Sector: Healthcare Industry: Biotech Market Cap: $24.67M Activated in VL: True Average Daily Range Avg Daily Range: $0.20 | 5.11% Avg Daily Range (30 D): $0.22 | 3.17% Avg Daily Range (90 D): $0.15 | 3.51% Institutional Daily Volume Avg Daily Volume: 1.19M Avg Daily Volume (30 D): .05M Avg Daily Volume (90 D): .36M Trade Size Avg Trade Size (Sh.): 244 Avg Trade Size (Sh.) (30 D): 121 Avg Trade Size (Sh.) (90 D): 430 Institutional Trades Total Inst.Trades: 58 Avg Inst. Trade: $1.06M Avg Inst. Trade (30 D): $.82M Avg Inst. Trade (90 D): $.82M Avg Inst. Trade Volume: .02M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $1.29M Avg Closing Trade (30 D): $1.31M Avg Closing Trade (90 D): $1.31M Avg Closing Volume: 11.75K     News Feb 7, 2025 @ 9:30 PM Tempest Reports Inducement Grant Under Nasdaq List... Source: N/A Jan 6, 2025 @ 1:00 PM Tempest Receives Orphan Drug Designation from the ... Source: N/A Dec 6, 2024 @ 9:30 PM Tempest Reports Inducement Grant Under Nasdaq List... Source: N/A Sep 20, 2024 @ 8:30 PM Tempest Reports Inducement Grants Under Nasdaq Lis... Source: N/A Jul 5, 2024 @ 1:10 PM $55M Bet On Archer Aviation? Check Out These 3 Pen... Source: Avi Kapoor, Benzinga Staff Writer Financials   TTM Q4 2024 FY 2024 Basic EPS $-3.16 $-.31 $-1.5 Diluted EPS $-3.16 $-.31 $-1.5 Revenue $ $ $ Gross Profit $ $ $ Net Income / Loss $ -10.86M $ -13.81M $ -41.84M Operating Income / Loss $ -10.94M $ -13.92M $ -42.03M Cost of Revenue $ $ $ Net Cash Flow $ M $ 7.8M $ -8.96M PE Ratio     Splits Apr 09, 2025:   1:13 Jun 28, 2021:   1:15